Keyphrases
Anti-CTLA-4
16%
Anti-programmed death-1 Monoclonal Antibody
16%
Anticancer Immunity
16%
Autoimmune Response
16%
Cancer Immune Evasion
100%
Cancer Immunotherapy
16%
CD33
16%
Cellular Expression
16%
Clinical Progress
16%
Colorectal Cancer
33%
Colorectal Cancer Patients
16%
Immune Checkpoint Inhibitors
16%
Immune Signaling
16%
Inhibitory Receptors
16%
Lung Cancer
16%
Molecular Patterns
100%
New Targets
16%
Non-small Cell Lung Cancer (NSCLC)
16%
Non-small Cell Lung Cancer Patients
16%
Ovarian Cancer Patients
16%
Pattern Recognition
16%
Polymorphism
16%
Programmed Death-ligand 1 (PD-L1)
16%
Receptor Binding
16%
Reduced Survival
16%
Sialic Acid Binding Immunoglobulin-like Lectins
100%
Sialoglycans
50%
Siglec
33%
Siglec-9
66%
T Cell Activation
16%
T Cells
100%
Treatment Failure
16%
Tumor-infiltrating T Cells
16%
Biochemistry, Genetics and Molecular Biology
Anticancer
12%
Autoimmunity
12%
Cancer Immunotherapy
12%
CD33
12%
Cell Activation
12%
CTLA-4
12%
Immune Checkpoints
12%
Immune Evasion
100%
Immune Receptor
12%
Immunoglobulin Binding
100%
Lectin
100%
Pattern Recognition
12%
Receptor Binding
12%
Sialic Acid
100%
Sialoglycoprotein
37%
Siglec
75%
T Cell
100%
Upregulation
12%